Piper Sandler lowered the firm’s price target on Align Technology (ALGN) to $275 from $285 and keeps an Overweight rating on the shares. The firm notes Align reported Q3 results that missed consensus expectations for clear aligner volumes and revenue, with management downshifting tone around U.S. consumer demand during the earnings call. Shares had a volatile after-market session but the stock is now indicating little changed, a reflection of pressure already experienced the last few weeks in the face of concerns around 2025 growth, Piper adds.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALGN:
- Align Technology price target lowered to $276 from $325 at Baird
- Align Technology sees Q4 revenue $995M-$1.015B, consensus $1.01B
- Align Technology introduces Invisalign Smile Architect
- Align Technology announces iTero intraoral scanner product innovations
- Align Technology reports Q3 adjusted EPS $2.35, consensus $2.31